Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This month, Dr Iztok Urbančič joined Christian Eggeling's lab in the MRC Human Immunology Unit, supported by a prestigious Marie Skłodowska-Curie postdoctoral fellowship. Iztok completed his studies in physics in 2009 at the University of Ljubljana, Slovenia, and obtained his PhD in biophysics in 2013 from the University of Maribor, Slovenia. During his 2-year fellowship here at the MRC WIMM, he will work on further improving super-resolution STED microscopy by introducing spectrally resolved detection in combination with environment selective probes. He will use these advancements to gain further insight into changes of molecular membrane organization and dynamics during immune cell activation.

Iztok_Urbancic

 

Similar stories

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Prof. Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

New study shines light on the complex mechanisms of Fetal Growth Restriction in pregnancy

The paper, published in Nature Communications reveals key genes involved in the common developmental disease.

Seven research groups secure LEAF Sustainability Awards

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.

Playful science at Wheatley and Holton Play and Activity Day 2022

On Saturday 16th July, volunteers from the MRC WIMM talked the science of blood, lab techniques and coding at the Play and Activity Day organised by the Oxfordshire Play Association.

Gold LEAF Award for Kusumbe Lab

The award demonstrates the group's commitment to sustainable science.

Novel all-in-one vaccine developed to tackle future coronavirus threats

Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.